 CAMBRIDGE, Mass., Jan. 19, 2021 GLOBE NEWSWIRE -- Genocea Biosciences, Inc . NASDAQ: GNCA, a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark, president and chief executive officer, will participate in a fireside chat at B. Riley Securities Virtual Oncology Investor Conference on January 21, 2021 from 11:00 am 11:30 am Eastern Time. A live webcast of the fireside chat will be available on the Genocea website at This event will also remain archived on the Genocea website for approximately 90 days. 